Clinical Report: Soluble CD147 in Plasma During Sepsis: Correlation with Disease Severity and Prognostic Implications

Overview

This study investigates the levels of soluble CD147 (sCD147) in plasma during sepsis and its correlation with disease severity and mortality. Elevated sCD147 levels were found to be associated with worse outcomes, including higher rates of acute kidney injury and disseminated intravascular coagulation.

Background

Sepsis is a critical condition characterized by a dysregulated host response to infection, leading to significant morbidity and mortality. Identifying reliable biomarkers for sepsis can aid in early diagnosis and management, potentially improving patient outcomes. Soluble CD147 has emerged as a candidate biomarker, but its clinical relevance in sepsis requires further exploration.

Data Highlights

Key Findings

• Septic patients had significantly higher sCD147 levels at ICU admission compared to non-septic controls and healthy donors (P < 0.001).
• sCD147 levels correlated positively with SOFA scores (r = 0.359; P < 0.001) and inflammatory mediators.
• Patients with acute kidney injury exhibited higher sCD147 levels compared to those without (P < 0.001).
• High sCD147 levels were predictive of mortality, with non-survivors showing higher levels than survivors (P < 0.001).
• Multivariable logistic regression identified sCD147 as an independent predictor of mortality (OR = 1.216; P = 0.001).

Clinical Implications

Monitoring sCD147 levels may provide valuable insights into the severity of sepsis and help identify patients at higher risk of mortality. However, further validation is necessary before integrating sCD147 into routine clinical practice as a prognostic tool.

Conclusion

The findings suggest that sCD147 is a promising biomarker for assessing disease severity and predicting outcomes in sepsis, warranting further investigation in diverse populations.

References

1. Intensive Care Medicine, 2010 -- Plasma Levels of Soluble ST2 as Predictors of Mortality in Patients with Severe Sepsis
2. Critical Care, 2025 -- Reduced plasma levels of Copine 5 correlate with sepsis-induced vascular leakage and mortality in human patients and a murine sepsis model
3. Critical Care, 2025 -- Assessment of Plasma Acid Sphingomyelinase Activity in Sepsis: Its Diagnostic Role and Correlation with Disease Severity
4. Intensive Care Medicine, 2012 -- Evaluating the Role of suPAR as a Biomarker in Systemic Inflammation and Infection: A Comprehensive Review
5. Surviving Sepsis Campaign Adult Guidelines | SCCM, 2026 -- Guidelines for Sepsis Management
6. Critical Care, 2026 -- Plasma soluble CD147 levels in sepsis: the association with disease severity and the prediction for clinical outcome
7. Annals of Intensive Care, 2025 -- Biomarkers to guide sepsis management
8. Surviving Sepsis Campaign Adult Guidelines | SCCM
9. Plasma soluble CD147 levels in sepsis: the association with disease severity and the prediction for clinical outcome
10. Biomarkers to guide sepsis management | Annals of Intensive Care | Springer Nature Link